Insights › Stocks
Moderna (MRNA) News Today
3 headlines on Moderna cleared our tape in the last 7 days with a measured price reaction attached. 2 of them moved the underlying at least 0.35% within fifteen minutes. The largest measured reaction was -3.30% on MRNA at Aug 27, 09:31 ET.
Price action when the news broke
09:31:01 ET
What moved MRNA — last 7 days
| Time | Headline | 1 min | 15 min | Volume |
|---|---|---|---|---|
| Aug 27, 16:00 ET | Moderna Says FDA Approved sBLAs For 2026-2027 Spikevax And mNEXSPIKE Formulas Targeting JN.1-Lineage XFG Subvariant; Says Vaccines Expected Available In Coming Days | -0.24% | +0.04% | 61k sh |
| Aug 27, 09:31 ET | Moderna Borrows $2 Billion To Expand Oncology Business | -1.54% | -3.30% | 1.8M sh |
| Aug 27, 07:22 ET | Reported: Moderna (MRNA) to offer USD 2bln of convertible senior notes | +0.49% | +0.57% | 192k sh |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Times are New York ET.
Our analysis
Moderna Has 9 Trials Riding on the Method That Just Worked
One adjuvant melanoma readout does not reprice a company. A 9-trial programme testing the same procedure in other cancers does.
Moderna Q2 2026: Revenue Beat Overshadowed by Norovirus Trial Miss
Moderna reported second-quarter 2026 results before the market opened on July 31, 2026.
Why Is Moderna Stock Up Today?
Moderna and Merck's personalised cancer vaccine met both Phase 3 endpoints. The release contained no hazard ratios.